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Psychology Interventions for
Patients With Heart Disease:
A Preliminary Randomized
Trial”
TO THE EDITOR: In a recent
randomized feasibility trial, Nikra-
han et al.1 found that positive psy-
chological interventions (PPIs) led
to significant improvements in psy-
chological wellbeing in patients who
had undergone a procedure to treat
cardiovascular disease. We were
enthused to see this line of inquiry
and agree this is a crucial step
in determining the generalizability
of PPIs in non-Western clinical
populations.
Although this study is a pre-
liminary randomized trial, we
would like to highlight a number
of methodological issues that
should be addressed in a definitive
trial. The preliminary trial com-
pared 3 separate PPIs (Seligman,
Lyubomirsky, and Fordyce) to a
wait-list control. Although this
facilitated comparison of the dif-
ferent PPIs with each other, and
against an inactive control group,
there are 2 key issues relating to the
trial design. First, this design can-
not rule out the possibility of
placebo or expectancy effects asso-
ciated with PPIs. Participants pre-
sumably believed that the PPI
activities were likely to be benefi-
cial, or at least, understood that the
facilitator held this belief. There-
fore, our first recommendation for
a definitive trial is that the effect of
the PPIs be contrasted with an
active control group (i.e., a control
group engaged in some cognitive orPsychosomatics ]:], ] 2016behavioral activity comparable to
that involved in the PPIs), to eval-
uate the unique contribution of
PPIs over and above placebo/
expectancy effects. The second con-
sideration relates to the social sup-
port implicit in the PPIs. Each of
the PPIs involved a degree of
weekly contact with other partici-
pants and the group facilitator,
providing opportunities to interact
and form relationships with peers
who also recently underwent a
medical procedure. Additionally,
the Lyubomirsky (week 2) and
Fordyce (week 1) interventions
contained explicit social support
components dedicated to building
relationship quality. The potential
for social support to enhance cop-
ing and improve psychological
wellbeing in patient samples is
well-established,2 and indeed, sup-
port is a known predictor of each of
the study outcomes.3 The benefits
of PPIs in this instance cannot be
clearly ascribed to the targeted
positive psychological constructs,
such as gratitude, kindness, mind-
fulness, flow or all of these. Thus,
our second recommendation for a
definitive trial is that it incorporates
a social support arm involving
comparable levels of social contact
with the facilitator, and with peers.
Next, we are interested to
observe differences in completion
rates across the 3 PPI groups. The
authors offer several possibilities for
these differences. This leads us to
suggest that future feasibility trials
on clinical samples could be greatly
enhanced by a qualitative evalua-
tion of the trial alongside the
quantitative evaluation. This wouldwallow researchers to understand par-
ticipant experiences of PPIs, identify
barriers to engagement and to com-
pletion, help identify the active
ingredients of PPIs, and determine
the groups for which PPIs might be
most likely to be acceptable and
beneficial.
Finally, we are impressed by the
authors’ engagement with the PPI
literature and their efforts to
develop comprehensive PPIs based
on the work of key researchers in
this field. Nonetheless, we observe
that many of the problems asso-
ciated with psychological interven-
tions generally are inherent in PPIs.
For example, in the field of behavior
change, researchers have advocated
for improvements in intervention
reporting, specification of the active
ingredients or “core intervention
component” necessary for an
intervention to work, and evalua-
tion of the fidelity with which an
intervention is delivered across
participants and contexts.4 These
same principles need to be
adopted for PPIs if they are to be
beneficial for patients with cardiac
disease.
In summary, as stated recently,5
the application of PPIs to people
with serious physical health impair-
ments needs to be done in a highly
sensitive manner, while maintaining
empirical rigor. Addressing the
methodological issues described
here is critical to determine the
efficacy (or otherwise) of PPIs in
clinical populations and healthcare
practice going forward.
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